Mean platelet volume predicts prognosis in patients with diffuse large B‐cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|36|1|104-109

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 104-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel agents for diffuse large B-cell lymphoma

By Sinha Rajni   DeJoubner Nutan   Flowers Christopher  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 669-680

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of the Addition of Rituximab to CHOP in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma

By Ferrara Felicetto  

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 55-65

Adis International

Access to resources Recommend Favorite

Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP

By  

Current Cancer Drug Targets, Vol. 14, Iss. 7, 2014-09 ,pp. : 659-670

Bentham Science Publishers

Access to resources Recommend Favorite

Age-related differences in quality of life among patients with diffuse large B-cell lymphoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2857-2858

Blackwell Publishing

Access to resources Recommend Favorite

Reply to age-related differences in quality of life among patients with diffuse large B-cell lymphoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2858-2859

Blackwell Publishing

Access to resources Recommend Favorite